HER-2/neu, Serum
Also known as: HER-2 Extracellular Domain (ECD), HER-2/neu Shed Antigen
Use
Quantitative measure of HER-2/neu in human serum. HER-2/neu values obtained may be used in the follow-up and monitoring of patients with metastatic breast cancer. HER-2/neu values should be used in conjunction with information available from clinical and other diagnostic procedures in the management of breast cancer. The clinical utility of the measurement of HER-2/neu as a prognostic indicator for early recurrence and in the management of patients on immunotherapy regimens has not been fully established.
Special Instructions
Not provided.
Limitations
Elevated levels of serum HER-2/neu are observed in a subset of patients with HER-2/neu-positive tumors. Approximately 25% to 30% of breast cancers demonstrate overexpression of the HER-2/neu protein. The clinical utility of the measurement of HER-2/neu as a prognostic indicator for early recurrence and in the management of patients on immunotherapy regimens has not been fully established.
Methodology
Immunoassay (ECLIA)
Biomarkers
HER-2/neu
Protein
LOINC Codes
- 42914-2 - Her2 Ag Ser IA-mCnc
- 42914-2 - Her2 Ag Ser IA-mCnc
- 80563-0 - Report
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Transfer serum to screw-cap tube for shipping. Freeze specimen at -20°C and ship on dry ice.
Storage Instructions
Freeze
Causes for Rejection
Hemolysis; defrosted or freeze-thawed specimen
Other tests from different labs that may be relevant
